Glaucio M. Ferreira

Sao Paulo, SP 05508000, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Synthetic Mimotopes of Salivary Peptides against SARS-CoV-2 In Vitro.

Synthetic Mimotopes of Salivary Peptides against SARS-CoV-2 In Vitro.

Journal: Journal of dental research

Published: August 16, 2025

Translational insights into statin-induced myotoxicity: Differential impact of lipophilic and hydrophilic statins on iPSC-derived skeletal muscle cells from patients with familial hypercholesterolemia.

Translational insights into statin-induced myotoxicity: Differential impact of lipophilic and hydrophilic statins on iPSC-derived skeletal muscle cells from patients with familial hypercholesterolemia.

Journal: Toxicology

Published: January 23, 2025

Correction to "Design, Synthesis, and Mechanistic Studies of (R)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase".

Correction to "Design, Synthesis, and Mechanistic Studies of (R)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase".

Journal: ACS chemical biology

Published: July 18, 2024

Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability.

Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability.

Journal: Pharmacogenetics and genomics

Published: April 29, 2024

Design, Synthesis, and Mechanistic Studies of (R)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase.

Design, Synthesis, and Mechanistic Studies of (R)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase.

Journal: ACS chemical biology

Published: April 17, 2024

Correction to: Innovative Microemulsion Loaded with Unusual Dimeric Flavonoids from Fridericia platyphylla (Cham.) L.G. Lohmann Roots.

Correction to: Innovative Microemulsion Loaded with Unusual Dimeric Flavonoids from Fridericia platyphylla (Cham.) L.G. Lohmann Roots.

Journal: AAPS PharmSciTech

Published: November 14, 2023

Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII.

Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII.

Journal: Journal of biomolecular structure & dynamics

Published: October 14, 2023

Exploring the conformational dynamics of the CRD4: a model for receptor lysosomal activity shifts in search of 'sweet' and 'sour' states.

Exploring the conformational dynamics of the CRD4: a model for receptor lysosomal activity shifts in search of 'sweet' and 'sour' states.

Journal: Journal of biomolecular structure & dynamics

Published: July 13, 2023

Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/Cas9 constructs.

Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/Cas9 constructs.

Journal: Gene

Published: July 12, 2023

Innovative Microemulsion Loaded with Unusual Dimeric Flavonoids from Fridericia platyphylla (Cham.) L.G. Lohmann Roots.

Innovative Microemulsion Loaded with Unusual Dimeric Flavonoids from Fridericia platyphylla (Cham.) L.G. Lohmann Roots.

Journal: AAPS PharmSciTech

Published: July 10, 2023

Dynamics of the personalities of PCSK9 on missense variants (rs505151 and rs562556) from elderly cohort studies in Brazil.

Dynamics of the personalities of PCSK9 on missense variants (rs505151 and rs562556) from elderly cohort studies in Brazil.

Journal: Journal of biomolecular structure & dynamics

Published: April 03, 2023

Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options.

Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 24, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026